Earth Science Tech, Inc. (OTC: ETST) has reported a 57% year-over-year increase in net income for its fiscal first quarter of 2027, reaching $715,697, as the company continues to expand its vertically integrated healthcare platform. The results, announced in a press release, highlight the company's ability to grow profitability despite a modest 3% rise in revenue to $9.0 million, driven by improved margins and operational efficiencies across its subsidiaries.
The company's gross profit climbed to $6.3 million, while operating cash flow more than doubled to $707,131, reflecting stronger cash generation from its compounding pharmacy, telemedicine, and direct-to-patient fulfillment operations. Total assets increased to $10.4 million, bolstering the company's balance sheet. Diluted earnings per share improved to $0.003 from $0.001 in the prior-year period, a sign of enhanced shareholder value.
Management emphasized that all key operating subsidiaries remained profitable during the quarter. The company also continued to expand the licensing footprint of its compounding pharmacy operations across the United States, a strategic move to broaden its market reach. Additionally, Earth Science Tech is evaluating opportunities to scale its telehealth and pharmacy fulfillment platforms, aiming to capitalize on the growing demand for integrated healthcare services.
During the quarter, the company repurchased and retired more than 3.7 million common shares without incurring additional debt, demonstrating a commitment to returning value to shareholders. This buyback program, coupled with the company's profitability, signals confidence in its long-term growth prospects.
Investors will have the opportunity to hear directly from management at the annual shareholder meeting scheduled for Aug. 31, 2026. The agenda includes a vote on the cancellation of the company's Series B Preferred Stock, a move that could simplify the capital structure. Additionally, management will provide updates on a potential exchange uplisting, which is aimed at improving liquidity and market visibility for the company's shares.
The positive financial results come as Earth Science Tech continues to build out its healthcare ecosystem, which integrates patient care from consultation to fulfillment. The company's subsidiaries work in synergy to provide a seamless experience, and this model appears to be gaining traction. The increase in net income and cash flow suggests that the company is effectively executing its growth strategy while maintaining financial discipline.
Looking ahead, the company's focus on expanding its pharmacy licensing and enhancing its digital health platforms positions it well in the evolving healthcare landscape. The potential uplisting to a national exchange could attract a broader investor base, potentially increasing trading liquidity and market recognition. As the company prepares for its annual meeting, stakeholders will be watching closely to see how these strategic initiatives unfold.
